Results

Total Results: 1,474 records

Showing results for "indication".
Users also searched for: medication reconciliation

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
    May 01, 2009 - ICD-9 code did not match with an FDA approved indication for the drug. … to support common use for the other indication. … Off- label Indication Third Most Common Off-label Indication 1 quetiapine Schizophrenia Bipolar … c The number of uses for this off-label drug indication exceeded that for its most common on-label indication … and diagnosis where a non-specific diagnosis was used and the indication was quite specific.
  2. effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
    January 01, 2013 - There is potential for confounding by indication or severity and selection bias associated with different … on indication or severity is unmeasured. … Even in analyses using calendar time as an instrumental variable, confounding by indication may still … Indication Another treatment used for the same indication as the exposure treatment typically is used … will often have to be ensured by defining the indication and restricting the study population.
  3. effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
    January 01, 2012 - Confounding by indication can be minimized by choosing a comparator that has the same indication, similar … Other aspects to consider when choosing a comparator include clearly defining the indication, initiation … information on indication or severity is unmeasured. … will often have to be ensured by defining the indication and restricting the study population. … Confounding by indication: an example of variation in the use of epidemiologic terminology.
  4. effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence-quiz.ppt
    May 29, 2025 - What is confounding by indication? … Assessing Bias in Observational Studies Assessing Bias in Observational Studies What is confounding by indication … Confounding by indication is a type of selection bias that occurs when study groups differ because they … It is often difficult to adjust for confounding by indication in analyses; therefore, studies with a … Studies with a high risk of bias due to confounding by indication are usually not suitable for inclusion
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence-quiz.ppt
    May 29, 2025 - What is confounding by indication? … Assessing Bias in Observational Studies Assessing Bias in Observational Studies What is confounding by indication … Confounding by indication is a type of selection bias that occurs when study groups differ because they … It is often difficult to adjust for confounding by indication in analyses; therefore, studies with a … Studies with a high risk of bias due to confounding by indication are usually not suitable for inclusion
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-summary.pdf
    November 01, 2020 -  Systematic reviews of harms (regardless of indication) report that acetaminophen, prednisolone, indomethacin … , we also searched for relevant SRs of interventions in women in the same phase, regardless of the indication … We identified indirect evidence (i.e., systematic reviews regardless of indication) that the following … We also identified indirect evidence (i.e., systematic reviews regardless of indication) that antihistamines … We identified indirect evidence (i.e., systematic reviews regardless of indication) that use of the
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
    September 07, 2012 - The review now includes a meta-analysis by indication. … The review now includes a meta-analysis by indication. … Across other forms, the studies lack similarity in indication and use. … Indication appears to have more weight than formulation as all formulation. … None of the tables make this indication either.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
    February 01, 2012 - They are distinguished in each by the specific indication and the type of transplant procedure, as … They are distinguished in each by the specific indication and the type of transplant procedure, as … Pediatric HSCT indications to be addressed with narrative review (continued) Type Disease Indication … Pediatric HSCT indications to be addressed with narrative review (continued) Type Disease Indication … The strength of the body of evidence for each indication was assessed.
  9. S13 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
    October 01, 2007 - vulnerable to random error, or confounding by a variable such as another drug, a disease, or the drug indication … stud- ies of the effectiveness of pharmaceuticals, present unique challenges involving confounding by indication … .12 People who receive a drug are different from people who do not, in that they have an indication for … This indication is commonly associated with the outcome under study, so unless the indication can be … Complete measurement of confound- ing by indication in this situation, on a longitudinal basis, is extraordinarily
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/unpublished-drug-trials-white-paper.pdf
    December 01, 2024 - After going through this process for the three drug-indication combinations, we conducted analyses only … FDA-Approved Indications Versus Off-Label Uses: FDA reviews only cover drug- indication combinations … Indication approval FDA-approved indications Off-label uses FDA reviews available only for approved … Approval timing First approved indication Subsequently approved indications As explained above … We searched for additional drug-indication pairs but did not find one suitable for analysis; for example
  11. effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
    January 01, 2013 - Confounding by indication leads to higher propensity for/more intensive treatment in those with the most … Confounding by indication leads to higher propensity for treatment or more intensive treatment in those … or an indication with a similar potential for confounding. … A comparator treatment within the same indication is likely to reduce the potential for bias from both … confounding by indication and confounding by frailty.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - † FDA indication as listed on the 510K preapproval documentation. … Only studies that evaluate interventions and comparators with a current indication approved by thus … For agents with an FDA-approved indication for the treatment of psoriasis, a search for completed trials … For agents with an FDA-approved indication for the treatment of psoriasis, a search for completed … approved indication for the treatment of psoriasis, a search for completed trials with posted results
  13. S131 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - Restricting study cohorts to patients who are homogeneous regarding their indication for the study drug … confounding by selecting patients with the same indication (eg, indication for using celecoxib vs. rofecoxib … by the initiation of a treatment specific to the indication. … Obviously, patients on therapy most likely have a medical indication; by contrast a large proportion … of nonusers have no medical indication.
  14. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-ki-tep-confidentiality-form.pdf
    August 01, 2020 - If they agree to provide comments, comments will be de-identified such that there will be no indication … If they agree to provide comments, comments will be de-identified such that there will be no indication
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - Introduction Indication/trial specific issues in analysis methodology The report acknowledges … In addition, we describe the criteria for combining certain studies on a given indication when the … behind decisions to pool, or not pool, studies (see specific sections for each indication entitled … As described above, for each indication, the report includes a section discussing heterogeneity and … needed so that the reporting of each key indication can stand on its own.
  16. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - However, in May 2014, Corcept halted development of mifepristone for this indication, citing a failure … (Minneapolis, MN); Medtronic has since abandoned clinical trials for this indication but has stated … Lisdexamfetamine’s manufacturer, Shire, plc (Dublin, Ireland), is pursuing an expanded indication for …  Key Expert Comments: Experts commenting on ketamine for this indication were optimistic about … FDA has granted fast-track status to esketamine for this indication, and Janssen has indicated plans
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0765-150129.pdf
    November 03, 2014 - children with chronic otitis media with effusion (OME) at different thresholds of frequency of clinical indication … children with recurrent acute otitis media (AOM) at different thresholds of frequency of clinical indication
  18. effectivehealthcare.ahrq.gov/sites/default/files/ch_2-user-guide-to-ocer_130129.pdf
    January 01, 2011 - .6-7 Confounding by indication leads to higher propensity for treatment or more intensive treatment … Choice of Comparators Both confounding by indication and confounding by frailty may be strongest and … or an indication with a similar potential for confounding.28 A comparator treatment within the … by indication and confounding by frailty. … Comparing different treatment options for a given patient (i.e., the same indication) is at the very
  19. effectivehealthcare.ahrq.gov/sites/default/files/selecting-evidence.ppt
    January 01, 2010 - Confounding by Indication Confounding by indication is a type of selection bias that occurs when groups … It is often difficult to adjust for confounding by indication; therefore, studies with a high degree … of potential bias because of confounding by indication are usually not suitable for inclusion in a comparative … Bias from confounding by indication can sometimes be mitigated by using propensity scores. … Confounding by indication is not much of an issue for unexpected or unpredictable harms, so observational
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/selecting-evidence.ppt
    January 01, 2010 - Confounding by Indication Confounding by indication is a type of selection bias that occurs when groups … It is often difficult to adjust for confounding by indication; therefore, studies with a high degree … of potential bias because of confounding by indication are usually not suitable for inclusion in a comparative … Bias from confounding by indication can sometimes be mitigated by using propensity scores. … Confounding by indication is not much of an issue for unexpected or unpredictable harms, so observational

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: